WASHINGTON— Life Sciences IP Review has named Covington partner Christopher Sipes Highly Commended for its Patent Litigator of the Year Award at the LSPN Awards 2026 ceremony in Boston. The Highly Commended distinction recognizes the highest-ranked finalist following the category winner and is determined by an independent panel of life sciences IP professionals from leading pharmaceutical companies and law firms.
The Patent Litigator of the Year Award recognizes a life sciences IP litigator who demonstrates exceptional legal acumen, strategic insight, and mastery of technical complexity while playing a pivotal role in shaping significant litigation outcomes through victories, settlements, or the successful defense or assertion of patent rights. Christopher was selected from a competitive field of finalists representing some of the nation's most accomplished patent litigators.
Christopher is a nationally recognized patent trial lawyer and Co‑Chair of Covington's Patent Litigation Group, with more than three decades of experience representing leading pharmaceutical and biotechnology innovators. His practice focuses on high‑stakes patent litigation, including Hatch‑Waxman and biologics disputes, FDA exclusivity challenges, PTAB proceedings, method‑of‑treatment patent cases, and complex multi‑defendant and multi‑jurisdictional matters. He regularly appears in federal district courts nationwide and before the Federal Circuit, and is widely trusted by top innovators to lead their most consequential, technically complex, and business‑critical IP disputes.
Covington was also a finalist for the LSPN Awards 2026 Case of the Year/Impact Case Award for its representation of Daiichi Sankyo in Seagen Inc. v. Daiichi Sankyo Co., Ltd., a matter led by Christopher, which resulted in the overturning of a multimillion‑dollar jury verdict. The firm was separately named Highly Commended for Life Sciences IP Litigation Firm of the Year at the same ceremony.
Back
